Scientists discover unexpected way alligators help the environment: 'Guardians of the Everglades'
They may look frightening, but alligators are great for the environment, which makes them great for us.
Alligators are ancient creatures, with ancestors dating back 245 million years, according to National Geographic. Although these reptiles can grow up to 12 feet, per the South Carolina Department of Natural Resources, and have a rather fearsome appearance, a new study suggests that they are a vital part of Florida's ecosystem, the BBC reported.
When it comes to animals and the environment, much of the debate covers the effects of methane from farming or the destruction of habitats impacting various species. However, what may be lesser known is that some animals have a positive impact on the environment around them, and alligators are one example.
The BBC report focused on members of the Miccosukee Tribe in the north of Florida's Everglades who live in harmony with a 60-year-old alligator playfully dubbed Mama Gator. This new research shows that alligators are "guardians of the Everglades" and help protect ecosystems.
These reptiles carry around nutrients that enrich ecosystems by traveling from marshes into freshwater, per the study published in the Journal of Animal Ecology. Their habitats and nests also provide shelter for frogs and fish and encourage plant growth, meaning that the area's biodiversity flourishes.
Alligators have faced near-extinction due to hunting and the fashion industry's penchant for leather, but conservationists helped save the species from being wiped out. Today, over 3 million alligators live in Florida and Louisiana, according to the BBC.
Saving a species from endangerment is a massive win for animals and humans alike. Now, more protections can be put in place to protect the species. With more knowledge of alligators' importance to ecosystems, people will be less likely to hunt them or cause damage to their habitats.
Conservation of land and the creatures that live there is vital for the planet's biodiversity. It not only helps prevent the extinction of animals but also provides natural beauty for people to enjoy and protects those who rely on these natural environments for food or employment.
From conserving forests and wetlands to eradicating invasive species, many scientists are working tirelessly to protect the flora and fauna that the planet relies on to survive.
For members of the Miccosukee Tribe, living in harmony with local animals is a way of life. Kendall Osceola, a staff member at the Miccosukee Indian Village cultural center, said: "We were always told if there's a body of water in Florida, there's going to be an alligator in there. … Yet Miccosukee stories depict them as 'benevolent creatures.'"
Should the government be paying people to hunt invasive species?
Definitely
Depends on the animal
No way
Just let people do it for free
Click your choice to see results and speak your mind.
Biologist Christopher Murray also hopes that humans and alligators can live in close proximity in peace: "Do they command respect? Yes. But are they monsters? Are they to be feared? No."
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
23 minutes ago
- Medscape
GLP-1 Users Should Fast 24 Hours Before Anesthesia
Patients taking the new class of weight-loss drugs do not need to stop these medications prior to procedures requiring anesthesia, but they should adhere to longer preoperative fasting times, according to a new multidisciplinary consensus statement. The statement, led by the Society for Perioperative Assessment and Quality Improvement, recommends patients without significant gastrointestinal symptoms associated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) should fast from solid foods for 24 hours and stick to clear liquids prior to a procedure requiring anesthesia. This extended fasting time can help mitigate aspiration risk in these patients with delayed gastric emptying while retaining the benefits of continuing GLP-1 RAs, such as improved glycemic control. The statement is 'the first to provide recommendations for perioperative management of patients taking GLP-1 RAs based on an in-depth systematic literature review of both clinical perioperative studies and gastric emptying data,' Adriana Oprea, MD, the first author of the document, and her colleagues wrote. Changing Guidance In June 2023, the American Society of Anesthesiologists (ASA) released the first guidance statement regarding preoperative management of patients on GLP-1 RAs, after some case reports documented aspiration events in these patients. While the number of these events is generally low and rates of aspiration appear to be similar between patients on GLP-1 RAs and the general population, 'people got really worried with these drugs because of [the] delayed gastric emptying,' Oprea, an associate professor of anesthesiology at Yale School of Medicine in New Haven, Connecticut, told Medscape Medical News . The 2023 ASA guidance recommended holding GLP-1 RAs for one half-life — a week for patients on long-acting medication and a day for short-acting GLP-1s. Due to a lack of adequate evidence at the time, the document suggested these patients should follow the standard ASA fasting guidelines of 8 hours after a full meal. However, evidence suggests stopping GLP-1s for one half-life is not enough for the effects on gastric emptying to subside, according to the new statement. For longer-acting drugs like dulaglutide, semaglutide, and tirzepatide, patients would need to discontinue these medications for several weeks to restore normal gastrointestinal motility. For patients with type 2 diabetes, discontinuation of these medications over this period could lead to poor glycemic control, which is linked to worse postoperative outcomes. For patients taking GLP-1 RAs for weight loss, restarting these medications can result in increased gastrointestinal symptoms, Oprea said, such as nausea, vomiting, diarrhea, or constipation. 'Because adverse effects are more prevalent at higher GLP-1 RA doses, discontinuation of these medications might lead to a high likelihood of side effects upon medication reinitiation or require reinitiation of therapy at lower doses followed by dose reescalation,' Oprea's group wrote. 'This is logistically difficult for both patients and treating clinicians.' In October 2024, the ASA, along with other professional societies, published updated practice guidance stating GLP-1 RAs may be continued preoperatively in patients without an elevated risk for delayed gastric emptying and aspiration. Those defined as 'higher risk' included patients in the escalation phase, on weekly dosing, on higher doses, and with gastrointestinal symptoms. The guidance advised these patients at higher risk for delayed stomach emptying can help mitigate aspiration risk by following a 24-hour liquid diet. This updated guidance also received some criticism. 'As of yet, no studies have reported a difference in the incidence of increased residual gastric content that would justify treating patients differently on the basis of dose regimen and/or treatment phase,' wrote Glenio B. Mizubuti, MD, PhD, of the Kingston General Hospital, in Kingston, Ontario, Canada, and his colleagues in a letter to Anesthesiology . 'Similarly, the absence of ongoing digestive symptoms, while somewhat reassuring, should not be taken as a definitive sign of an empty stomach in GLP-1 RA users,' they wrote. Continue Meds, Extend Fasting Times This new consensus statement, published last month in the British Journal of Anaesthesia , recommends patients doing well on GLP-1 RAs should continue these medications preoperatively and follow a clear liquid diet for 24 hours before procedures requiring anesthesia. The recommendations were based on a systematic review of 112 studies and a modified Delphi process and were co-sponsored and endorsed by the American Association of Clinical Endocrinology. 'From our review of the literature, we feel that the fasting times are the most important factor that could decrease the risk of having residual gastric content in the stomach in a patient on GLP-1 RAs when they're scheduled to have a procedure that requires anesthesia,' Oprea said. The consensus also recommends patients on GLP-1s fast from high-carbohydrate-content clear liquids (containing 10% or more glucose) for 8 hours before and stop drinking any liquids four hours before these procedures. Inpatient and outpatients can restart GLP-1 RAs when they resume their original diets. Patients with significant gastrointestinal symptoms including severe nausea, vomiting, and inability to tolerate oral intake should postpone elective procedures that require anesthesia and refer to their prescribing physician for diet and medication modifications to manage symptoms, the authors advised. 'Our recommendation for a clear liquid diet for 24 hours preprocedurally might appear overly restrictive. However, evidence points to the safety of this approach in patients on GLP-1 RAs,' they wrote.
Wall Street Journal
41 minutes ago
- Wall Street Journal
A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech
Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to prevent HIV—a milestone in the decadeslong fight against a once-devastating disease. For Gilead Sciences GILD -0.28%decrease; red down pointing triangle, the dominant player in HIV treatment, the breakthrough is doing what years of splashy but underwhelming acquisitions failed to achieve: It has Wall Street paying attention again. Since reporting last June that just two annual shots of lenacapavir prevented all HIV infections in a study of women and girls, shares have surged 73%.
Fast Company
an hour ago
- Fast Company
The real data revolution hasn't happened yet
The Gartner Hype Cycle is a valuable framework for understanding where an emerging technology stands on its journey into the mainstream. It helps chart public perception, from the 'Peak of Inflated Expectations' through the 'Trough of Disillusionment,' and eventually up the 'Slope of Enlightenment' toward the 'Plateau of Productivity.' In 2015, Gartner removed big data from the Hype Cycle. Analyst Betsy Burton explained that it was no longer considered an 'emerging technology' and 'has become prevalent in our lives.' She's right. In hindsight, it's remarkable how quickly enterprises recognized the value of their data and learned to use it for their business advantage. Big data moved from novelty to necessity at an impressive pace. Yet in some ways, I disagree with Gartner. Adoption has been widespread, but effectiveness is another matter. Do most enterprises truly have the tools and infrastructure to make the most of the data they hold? I don't believe they do. Which is why I also don't believe the true big data revolution has happened yet. But it's coming. Dissecting the Stack A key reason big data is seen as mature, even mundane, is that people often confuse software progress with overall readiness. The reality is more nuanced. Yes, the software is strong. We have robust platforms for managing, querying, and analyzing massive datasets. Many enterprises have assembled entire software stacks that work well. But that software still needs hardware to run on. And here lies the bottleneck. Most data-intensive workloads still rely on traditional central processing units (CPUs)—the same processors used for general IT tasks. This creates challenges. CPUs are expensive, energy hungry, and not particularly well suited to parallel processing. When a query needs to run across terabytes or even petabytes of data, engineers often divide the work into smaller tasks and process them sequentially. This method is inefficient and time-consuming. It also ends up requiring more total computation than a single large job would. Even though CPUs can run at high clock speeds, they simply don't have enough cores to efficiently handle complex queries at scale. As a result, hardware has limited the potential of big data. But now, that's starting to change with the rise of accelerated computing. Breaking the Bottleneck Accelerated computing refers to running workloads on specialized hardware designed to outperform CPUs. This could mean field-programmable gate arrays (FPGAs) or application-specific integrated circuits (ASICs) built for a specific task. More relevant to big data, though, are graphics processing units (GPUs). GPUs contain thousands of cores and are ideal for tasks that benefit from parallel processing. They can dramatically speed up large-scale data operations. Interestingly, GPU computing and big data emerged around the same time. Nvidia launched CUDA (compute unified device architecture) in 2006, enabling general-purpose computing on graphics hardware. Just two years earlier, Google's MapReduce paper laid the foundation for modern big data processing. Despite this parallel emergence, GPUs haven't become a standard part of enterprise data infrastructure. That's due to a mix of factors. For one, cloud-based access to GPUs was limited until relatively recently. When I started building GPU-accelerated software, SoftLayer—now absorbed into IBM Cloud—was the only real option. There was also a perception problem. Many believed GPU development was too complex and costly to justify, especially for general business needs. And for a long time, few ready-made tools existed to make it easier. Those barriers have largely fallen. Today, a rich ecosystem of software exists to support GPU-accelerated computing. CUDA tools have matured, benefiting from nearly two decades of continuous development. And renting a top-tier GPU, like Nvidia's A100, now costs as little as $1 per hour. With affordable access and a better software stack, we're finally seeing the pieces fall into place. The Real Big Data Revolution What's coming next will be transformative. Until now, most enterprises have been constrained by hardware limits. With GPU acceleration more accessible and a mature ecosystem of supporting tools, those constraints are finally lifting. The impact will vary by organization. But broadly, companies will gain the ability to run complex data operations across massive datasets, without needing to worry about processing time or cost. With faster, cheaper insights, businesses can make better decisions and act more quickly. The value of data will shift from how much is collected to how quickly it can be used. Accelerated computing will also enable experimentation. Freed from concerns about query latency or resource drain, enterprises can explore how their data might power generative AI, smarter applications, or entirely new user experiences. Gartner took big data off the Hype Cycle because it no longer seemed revolutionary. Accelerated computing is about to make it revolutionary again.
